[Research advances on hepatocyte zonal changes in metabolic associated fatty liver disease]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLi Y, Huang ZW, Gan JT, Zhang QF, Fu WW.
europepmc +1 more source
[Research progress on the effects of time-restricted eating on metabolic associated fatty liver disease]. [PDF]
Zhonghua Gan Zang Bing Za ZhiJiang ZQ, Wei TJ, Li GX.
europepmc +1 more source
[A review of research progress in integrated traditional Chinese and Western Medicine for liver diseases]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhang Q +6 more
europepmc +1 more source
[Introduction to the recommendations of the EASL clinical practice guidelines for genetic cholestatic liver diseases]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHou W, Zheng SJ.
europepmc +1 more source
[Periodontitis and Metabolic Dysfunction-Associated Fatty Liver Disease: From Oral Dysbiosis to Hepatic Metabolic Dysregulation]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanWang M +5 more
europepmc +1 more source
[Recommendations from the European Association for the Study of the Liver and the European Reference Network for Rare Liver Diseases Clinical Practice Guidelines for hepatolenticular degeneration]. [PDF]
Zhonghua Gan Zang Bing Za ZhiTang S, Hou W, Zheng SJ.
europepmc +1 more source
[Inherited metabolic liver disease causing copper deposition]. [PDF]
Zhonghua Gan Zang Bing Za ZhiJiang H, Liang C, Liu H, Zheng SJ.
europepmc +1 more source
[Research progress on the mechanisms and optimization strategies of mesenchymal stem cell-derived exosomes in the treatment of liver diseases]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLi XR, Niu B, Zhang LY.
europepmc +1 more source
[Scutellarin improves metabolic dysfunction-associated steatotic liver disease in rats by regulating MMP7 and LCN2]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoMa Y +5 more
europepmc +1 more source